Here is how Gerald raises the pps above .10 cents
Post# of 30028
I don't know exactly where AMBS is in the "soft selling" process of Lymrpo to AD pharmas. JP mentioned yesterday that it would be nice to see a "work order" for LymPro on an AD trial starting in December.
I don't think it would take very much of this kind of evidence to instill confidence in the market about LymPro and AMBS.